Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Status: | Completed |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/8/2018 |
Start Date: | September 2009 |
End Date: | January 2016 |
A Phase II Evaluation of AZD6244 (NSC #748727) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
This phase II trial is studying how well selumetinib works in treating patients with
recurrent or persistent endometrial cancer that has come back or is persistent. Selumetinib
may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
recurrent or persistent endometrial cancer that has come back or is persistent. Selumetinib
may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
PRIMARY OBJECTIVES:
I. To assess the activity of AZD6244 (selumetinib) for patients with recurrent or persistent
endometrial cancer with the frequency of patients who survive progression-free for at least 6
months after initiating therapy or have objective tumor response.
II. To determine the nature and degree of toxicity of AZD6244 as assessed by CTCAE v3.0 in
this cohort of patients.
SECONDARY OBJECTIVE:
I. To determine the duration of progression-free survival and overall survival.
EXPLORATORY OBJECTIVES:
I. To explore the associations between select biomarkers and response to AZD6244
(progression-free survival status >6 months and objective tumor response), measures of
clinical outcome (progression-free survival and overall survival) or disease status including
histologic cell type.
II. Mutations and single nucleotide polymorphisms in BRAF, KRAS2, FGFR2, PI3KCA, AKT1, AKT2,
AKT3 and PTEN in DNA from formalin-fixed and paraffin-embedded (FFPE) tumor and/or normal
blood cells.
III. Immunohistochemical expression of ERK, pERK, GSK3betta, pGSK3betta, PR-A, PR-B, pPR,
ER-alpha, ER-beta, BRAF, KRAS, PTEN, EGFR, pEGFR, EGF, PELP1 and MTA1s in FFPE tumor.
IV. To explore the relationship among the panel of biomarkers evaluated in this cohort
including mutations and single nucleotide polymorphisms in BRAF, KRAS2, FGFR2, PI3KCA, AKT1,
AKT2, AKT3 and PTEN as well as immunohistochemical expression of ERK, pERK, GSK3betta,
pGSK3betta, PR-A, PR-B, pPR, ER-alpha, ER-beta, BRAF, KRAS, PTEN, EGFR, pEGFR, EGF, PELP1 and
MTA1s.
OUTLINE: This is a multicenter study.
Patients receive selumetinib orally (PO) twice daily on days 1-28. Courses repeat every 28
days in the absence of disease progression or unacceptable toxicity. Blood and archived tumor
tissue samples are collected for biomarker studies.
After completion of study therapy, patients are followed up every 3 months for 2 years and
then every 6 months for 3 years.
I. To assess the activity of AZD6244 (selumetinib) for patients with recurrent or persistent
endometrial cancer with the frequency of patients who survive progression-free for at least 6
months after initiating therapy or have objective tumor response.
II. To determine the nature and degree of toxicity of AZD6244 as assessed by CTCAE v3.0 in
this cohort of patients.
SECONDARY OBJECTIVE:
I. To determine the duration of progression-free survival and overall survival.
EXPLORATORY OBJECTIVES:
I. To explore the associations between select biomarkers and response to AZD6244
(progression-free survival status >6 months and objective tumor response), measures of
clinical outcome (progression-free survival and overall survival) or disease status including
histologic cell type.
II. Mutations and single nucleotide polymorphisms in BRAF, KRAS2, FGFR2, PI3KCA, AKT1, AKT2,
AKT3 and PTEN in DNA from formalin-fixed and paraffin-embedded (FFPE) tumor and/or normal
blood cells.
III. Immunohistochemical expression of ERK, pERK, GSK3betta, pGSK3betta, PR-A, PR-B, pPR,
ER-alpha, ER-beta, BRAF, KRAS, PTEN, EGFR, pEGFR, EGF, PELP1 and MTA1s in FFPE tumor.
IV. To explore the relationship among the panel of biomarkers evaluated in this cohort
including mutations and single nucleotide polymorphisms in BRAF, KRAS2, FGFR2, PI3KCA, AKT1,
AKT2, AKT3 and PTEN as well as immunohistochemical expression of ERK, pERK, GSK3betta,
pGSK3betta, PR-A, PR-B, pPR, ER-alpha, ER-beta, BRAF, KRAS, PTEN, EGFR, pEGFR, EGF, PELP1 and
MTA1s.
OUTLINE: This is a multicenter study.
Patients receive selumetinib orally (PO) twice daily on days 1-28. Courses repeat every 28
days in the absence of disease progression or unacceptable toxicity. Blood and archived tumor
tissue samples are collected for biomarker studies.
After completion of study therapy, patients are followed up every 3 months for 2 years and
then every 6 months for 3 years.
Inclusion Criteria:
- Histologically confirmed* endometrial epithelial carcinoma, including any of the
following cell types:
- Endometrioid adenocarcinoma
- Serous adenocarcinoma
- Undifferentiated carcinoma
- Clear cell adenocarcinoma
- Mixed epithelial carcinoma
- Adenocarcinoma not otherwise specified
- Mucinous adenocarcinoma
- Squamous cell carcinoma
- Transitional cell carcinoma
- Mesonephric carcinoma
- Recurrent or persistent disease that is refractory to curative therapy or established
treatments
- Measurable disease, defined as ≥ 1 lesion that can be measured in ≥ 1 dimension
(longest dimension to be recorded)
- Each lesion must be ≥ 20 mm when measured by conventional techniques (palpation,
plain x-ray, CT scan, or MRI) OR ≥ 10 mm when measured by spiral CT scan
- Must have ≥ 1 target lesion to be used to assess response, as defined by RECIST
criteria
- Tumors within a previously irradiated field are designated as "non-target"
lesions unless progression is documented or a biopsy is obtained to confirm
persistence ≥ 90 days following completion of radiotherapy
- Must have received 1 prior chemotherapeutic regimen for the management of endometrial
carcinoma
- Chemotherapy administered as a radiosensitizer in conjunction with primary
radiotherapy is considered a systemic chemotherapy regimen
- Not eligible for a higher priority GOG protocol, if one exists (e.g., any active phase
III GOG protocol for the same patient population)
- No prior or concurrent CNS disease (treated or untreated) by physical examination,
including primary brain tumor or brain metastases
- GOG performance status (PS) 0-2 (for patients who received 1 prior treatment regimen)
- GOG PS 0-1 (for patients who received 2 prior treatment regimens)
- ANC ≥ 1,500/mm^3
- Platelet count ≥ 100,000/mm^3
- Creatinine ≤ 1.5 times upper limit of normal (ULN)
- Bilirubin ≤ 1.5 times ULN
- SGOT ≤ 2.5 times ULN
- Alkaline phosphatase ≤ 2.5 times ULN
- PT/INR ≤ 1.5 OR in-range INR (between 2 and 3) if patient is on a stable dose of
therapeutic warfarin
- PTT ≤ 1.5 times ULN
- Oxygen saturation ≥ 88% on room air
- QTc < 450 msec by EKG
- LVEF normal
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception during and for ≥ 6 months after
completion of study therapy
- No neuropathy (sensory or motor) > grade 1
- No active infection requiring antibiotics
- Uncomplicated urinary tract infection allowed
- No other invasive malignancy within the past 5 years except for nonmelanoma skin
cancer
- No serious, non-healing wound, ulcer, or bone fracture
- No history of abdominal fistula or gastrointestinal perforation
- No intra-abdominal abscess within the past 28 days
- No active bleeding or pathological condition that would carry a high risk of bleeding
(e.g., bleeding disorder, coagulopathy, or tumor involving major vessels)
- No seizures not controlled with standard medical therapy
- No clinically significant cardiovascular disease including, but not limited to, any of
the following:
- Uncontrolled hypertension, defined as systolic BP > 140 mm Hg or diastolic BP >
90 mm Hg
- Myocardial infarction or unstable angina within the past 6 months
- NYHA class II-IV congestive heart failure
- Serious cardiac arrhythmia requiring medication, including atrial fibrillation
requiring rate-controlling medication
- Peripheral vascular disease ≥ grade 2
- Cerebrovascular accident (i.e., CVA, stroke), transient ischemic attack, or
subarachnoidal hemorrhage within the past 6 months
- No evidence of serious ventricular arrhythmia (i.e., ventricular tachycardia or
ventricular fibrillation ≥ 3 beats in a row) by EKG
- Concurrent low molecular weight heparin for treatment of venous thromboembolic disease
allowed provided patient is considered clinically stable on this regimen
- Recovered from prior surgery, radiotherapy, or chemotherapy
- At least 1 week since prior hormonal therapy directed at the malignant tumor
- At least 3 weeks since prior radiotherapy or chemotherapy (6 weeks for nitrosoureas or
mitomycin C)
- At least 3 weeks since other prior therapy directed at the malignant tumor, including
immunologic agents
- One prior cytotoxic regimen for the management of recurrent or persistent endometrial
disease allowed
- No prior non-cytotoxic chemotherapy for the management of endometrial cancer, except
hormonal therapy
- No prior anticancer therapy that contraindicates study therapy
- No prior MEK inhibitor AZD6244 or other specific MEK/ERK/MAPK pathway targeted therapy
- No prior chemotherapy for any abdominal or pelvic tumor other than for the treatment
for endometrial cancer within the past 5 years
- Prior adjuvant chemotherapy for localized breast cancer allowed provided it was
completed > 3 years ago AND the patient remains free of recurrent or metastatic
disease
- No prior radiotherapy to any portion of the abdominal cavity or pelvis other than for
the treatment of endometrial cancer within the past 5 years
- Prior radiotherapy for localized cancer of the breast, head and neck, or skin is
allowed provided it was completed > 3 years ago AND the patient remains free of
recurrent or metastatic disease
- No concurrent medication that may prolong the QTc interval
- No other concurrent investigational therapy
- No concurrent combination antiretroviral therapy for HIV-positive patients
We found this trial at
72
sites
Heartland Regional Medical Center Heartland Regional Medical Center is your community healthcare provider; a 98-bed...
Click here to add this to my saved trials
Hurley Medical Center From its founding in 1908, Hurley Medical Center has devoted itself to...
Click here to add this to my saved trials
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
Click here to add this to my saved trials
Bronson Methodist Hospital Our healthcare system serves patients and families throughout southwest Michigan and northern...
Click here to add this to my saved trials
West Michigan Cancer Center In 1994, Borgess Health Alliance and Bronson Healthcare Group opened the...
Click here to add this to my saved trials
Abington Memorial Hospital Abington Memorial Hospital (AMH) is a 665-bed, regional referral center and teaching...
Click here to add this to my saved trials
Saint Joseph Mercy Hospital St. Joseph Mercy Ann Arbor Hospital is a 537-bed teaching hospital...
Click here to add this to my saved trials
Click here to add this to my saved trials
13001 E. 17th Pl.
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
University of Colorado Cancer Center - Anschutz Cancer Pavilion The University of Colorado Denver |...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Bryn Mawr Hospital Bryn Mawr Hospital, a nationally recognized community teaching hospital, is conveniently located...
Click here to add this to my saved trials
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
Chicago, Illinois 60637
1-773-702-6180
University of Chicago Comprehensive Cancer Center The University of Chicago Comprehensive Cancer Center (UCCCC) is...
Click here to add this to my saved trials
University of Cincinnati The University of Cincinnati offers students a balance of educational excellence and...
Click here to add this to my saved trials
Click here to add this to my saved trials
Mercy Cancer Center - West Lakes When it comes to cancer care, there
Click here to add this to my saved trials
Riverside Methodist Hospital Serving central Ohio since 1892, Riverside Methodist Hospital is consistently ranked one...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Mercy Medical Center - Des Moines Mercy Medical Center
Click here to add this to my saved trials
Iowa Methodist Medical Center Iowa Methodist Medical Center was established in 1901 in a single...
Click here to add this to my saved trials
Iowa Lutheran Hospital Iowa Lutheran Hospital has a long history of serving the Des Moines...
Click here to add this to my saved trials
Saint John Hospital and Medical Center Founded in 1952, St. John Hospital and Medical Center...
Click here to add this to my saved trials
420 S Saginaw St
Flint, Michigan 48502
Flint, Michigan 48502
810-232-3522
Genesys Regional Medical Center-West Flint Campus The health care team at Genesys Downtown Flint Health...
Click here to add this to my saved trials
The Hartford Hospital Hartford Hospital is the major teaching hospital affiliated with the University of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
535 Barnhill Dr
Indianapolis, Indiana 46202
Indianapolis, Indiana 46202
(888) 600-4822
Indiana University Melvin and Bren Simon Cancer Center At the IU Simon Cancer Center, more...
Click here to add this to my saved trials
Click here to add this to my saved trials
Allegiance Health Allegiance Health is a community-owned and locally-governed health system in Jackson, Michigan. We...
Click here to add this to my saved trials
Borgess Medical Center At Borgess, healing is our calling. This is the place where people...
Click here to add this to my saved trials
Click here to add this to my saved trials
Truman Medical Center Located in the heart of downtown Kansas City, TMC Hospital Hill is...
Click here to add this to my saved trials
Saint Luke's Hospital, Kansas City Saint Luke's Hospital is a not-for-profit tertiary referral center committed...
Click here to add this to my saved trials
North Kansas City Hospital Generations of Northlanders have considered North Kansas City Hospital as their...
Click here to add this to my saved trials
5400 N Oak Trafficway, Suite 101
Kansas City, Missouri 64118
Kansas City, Missouri 64118
(855) 603-3282
Heartland Hematology Oncology Associates, Incorporated Heartland Hematology-Oncology Associates PA in Kansas, Missouri, is a private...
Click here to add this to my saved trials
Research Medical Center Research Medical Center offers hospital and health clinic services across three Kansas...
Click here to add this to my saved trials
Sparrow Hospital Sparrow has grown to become the region's largest health system, and its diverse...
Click here to add this to my saved trials
Women's Cancer Center of Nevada The Women's Cancer Center is a recognized leader in the...
Click here to add this to my saved trials
Saint Luke's East - Lee's Summit Founded in 2006, Saint Luke
Click here to add this to my saved trials
Liberty Hospital Liberty Hospital is a comprehensive medical center with a full range of services,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Los Angeles County-USC Medical Center The origins of LAC+USC Medical Center date back to 1878,...
Click here to add this to my saved trials
1441 Eastlake Ave
Los Angeles, California 90033
Los Angeles, California 90033
(323) 865-3000
U.S.C./Norris Comprehensive Cancer Center The USC Norris Comprehensive Cancer Center, located in Los Angeles, is...
Click here to add this to my saved trials
The Hospital of Central Connecticut The Hospital of Central Connecticut is dedicated to fostering, sustaining...
Click here to add this to my saved trials
940 NE 13th St
Oklahoma City, Oklahoma 73190
Oklahoma City, Oklahoma 73190
(405) 271-6458
University of Oklahoma Health Sciences Center The OU Health Sciences Center is composed of seven...
Click here to add this to my saved trials
Menorah Medical Center Menorah Medical Center (MMC), a full-service, acute care hospital located on the...
Click here to add this to my saved trials
Saint Luke's South Hospital Saint Luke's South Hospital is a comprehensive health care facility serving...
Click here to add this to my saved trials
Paoli Memorial Hospital Paoli is recognized regionally and nationally for outstanding medical and surgical services,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Saint Joseph Mercy Port Huron St. Joseph Mercy Hospital, Port Huron, MI is a 164-bed...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Saint Mary's of Michigan At St. Mary's of Michigan, we continue to grow our outreach...
Click here to add this to my saved trials
902 N. Riverside Road
Suite 200
Saint Joseph, Missouri 64507
Saint Joseph, Missouri 64507
(816) 271-1301
Saint Joseph Oncology, Inc. Founded in St. Joseph in 1984, Heartland Health seeks to improve...
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
Click here to add this to my saved trials
Memorial Medical Center Memorial Medical Center is a Magnet-designated, acute care hospital in Springfield that...
Click here to add this to my saved trials
Click here to add this to my saved trials
CoxHealth South Hospital U.S. News & World Report has ranked CoxHealth one of Missouri's best...
Click here to add this to my saved trials
Click here to add this to my saved trials
Saint John Macomb-Oakland Hospital St. John Macomb-Oakland Hospital, Macomb Center, is a 376-bed facility offering...
Click here to add this to my saved trials
Click here to add this to my saved trials
Methodist West Hospital Methodist West Hospital has become the "go-to" destination for medical care. Our...
Click here to add this to my saved trials
Mercy Medical Center-West Lakes Mercy Medical Center-West Lakes is a 146-bed, full-service community hospital situated...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials